一个新的框架来评估血液学和瘤学注册试验:The THEOREMM项目
Timothée Olivier1, Alyson Haslam2, Patricia Burke3
1Department of Oncology, Geneva University Hospital, Geneva, Switzerland.
European journal of clinical investigation
|June 27, 2024
概括
提出了一个新的框架来评估瘤学和血液学临床试验,解决当前评估的局限性. 这旨在提高癌症研究中药物批准决策的可靠性.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 临床试验方法论 临床试验方法论
背景情况:
- 瘤学和血液学试验的方法限制可能会影响结果的适用性.
- 低于最佳的对照手臂或有限的护理机会可能会导致试验结果偏差.
- 现有的评估工具往往无法整合这些关键试验缺陷.
研究的目的:
- 提出一个评估血液学和瘤学癌症临床试验注册的新框架.
- 解决目前试验评估中缺乏考虑关键局限性的问题.
- 创建一个框架来评估导致营销许可的单项试验.
主要方法:
- 组建一个科学委员会,并通过协议化方法定义范围,目标和方法.
- 对瘤学试验中的局限性和偏见进行范围审查,并评估现有方法.
- 通过专家瘤学家和血液学家的问卷来制定和评估特征清单.
主要成果:
- 不适用于这个提案阶段.
结论:
- 需要一个新的框架来解决目前癌症试验评估的局限性.
- 拟议的框架将专门评估在瘤学和血液学中获得营销许可的单项试验.
更多相关视频
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.2K
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
16.7K
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
